Compound Detail
CHEMBL437716
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCCCCCCCCC(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Basic Information
| ChEMBL ID | CHEMBL437716 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VTASNVPQADZTNQ-OLPGORLFSA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
768.1
MW (Da)
10.77
ALogP
5
HBA
3
HBD
130.0
PSA (Ų)
0.08
QED
2
Ro5 Violations
17
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 8.15
IC50 1 meas. best 4.96
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 7.0 | nM | 8.15 | Antiviral activity against HIV1 NL4-3 in MT4 cells | 16942019 |
| MT4 | IC50 | = | 11000.0 | nM | 4.96 | Cytotoxicity against human MT4 cells | 16942019 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16942019 | 10.1021/jm0601912 | MT4 | 2 |
| 16942019 | 10.1021/jm0601912 | ADMET | 1 |
| 16942019 | 10.1021/jm0601912 | H9 | 1 |
Data from ChEMBL 36 via Core Engine